Quick Takeaways
- GordonMD Global Investments LP filed SCHEDULE 13G for Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share (KYTX).
- Disclosed ownership: 7%.
- Date of event: 13 Nov 2025.
Quoteable Key Fact
"GordonMD Global Investments LP disclosed 7% ownership in Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share (KYTX) on 13 Nov 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| GordonMD Global Investments LP | 7% | 3,058,485 | 0 | 3,058,485 | /s/ GordonMD Global Investments GP LLC | Craig D. Gordon / Managing Member of the General Partner | |
| GordonMD Long Biased Master Fund LP | 6.2% | 2,735,783 | 0 | 2,735,783 | /s/ GordonMD Long Biased GP LLC | GordonMD Long Biased GP LLC / Managing Member of the General Partner | |
| GordonMD Long Biased GP LLC | 6.2% | 2,735,783 | 0 | 2,735,783 | /s/ Craig D. Gordon | Craig D. Gordon / Managing Member | |
| Craig D. Gordon | 7% | 3,058,485 | 0 | 3,058,485 | /s/ Craig D. Gordon | Craig D. Gordon | |
| GordonMD Global Investments GP LLC | 7% | 3,058,485 | 0 | 3,058,485 | /s/ Craig D. Gordon | Craig D. Gordon / Managing Member |